Kyverna Therapeutics (KYTX) stock: insider trades, news & valuation
Net buyingShare price and insider trades
Kyverna Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $2.0M and 1 sold $293K of KYTX stock on the open market.
Get emailed when insiders cluster-buy stocks like KYTX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
KYTX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $2.0M | 2 | $293K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 2 Kyverna Therapeutics, Inc. insiders reported open-market purchases totaling $2.0M, while 1 insider reported sales totaling $293K. 1 of 1 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Dec 22SEC | Beth C SeidenbergDirector | Buy | 133,333869,317 held (+18%) | $7.50 | $1000K | -14.8% | — |
| Dec 22SEC | Westlake Biopartners Opportunity Fund I, L.P.10% Owner | Buy | 133,333869,317 held (+18%) | $7.50 | $1000K | -14.8% | — |
| Dec 17SEC | Karen Marie WalkerCTO | Sell Plan | 23,99822,636 held (−51%) | $12.20 | $293K | -47.6% | — |
Insiders at Kyverna Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Beth C SeidenbergDirector | $1000K | — | Dec 22, 2025 | — |
| Westlake Biopartners Opportunity Fund I, L.P.10% Owner | $1000K | — | Dec 22, 2025 | — |
| Karen Marie WalkerCTO | — | $293K | Dec 17, 2025 | — |
KYTX stock: common questions
Are Kyverna Therapeutics, Inc. insiders buying KYTX stock?
In the past 12 months, 2 insiders reported open-market purchases of KYTX worth $2.0M. The latest was Director Beth C Seidenberg bought $1000K of KYTX at $7.50 — first open-market purchase in our records.
Are Kyverna Therapeutics, Inc. insiders selling KYTX stock?
1 insiders reported sales worth $293K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is KYTX's 52-week range?
Over the past year KYTX has traded between $6.16 and $11.25. It last closed at $6.39 on Oct 9, 2026.